News & Media

Whatever the end goal of your large-scale EV production, the Exoid can help keep you on track.

When it comes to measuring particle size in the field of nanomedicine, how do TRPS and DLS compare?

A summary of work by Martinelli et al. (2020) who describe the production of extracellular vesicle (EV)-inspired nanoparticles for drug delivery, and used Tunable Resistive Pulse Sensing to characterise the vesicles.

From Arabidopsis thaliana to red cabbage, the field of plant EV (and EV-like nanoparticle) research is a fast-changing world of basic biology and therapeutics. So why is methodology stuck in the past?

When your research relies on knowing the absolute size of the particles, accuracy is essential. Learn how the Exoid is providing high precision data to improve our understanding of particle behaviour.

The collaborative agreement between Izon Science and ABT offers exceptional opportunities to develop solutions that aid in advancing EV research into clinical settings.

The Gen 2 qEV range provides a strong foundation for extracellular vesicle isolation, paving the way towards a future where EVs shape clinical decisions and health outcomes. Here, we share an overview and key resources related to qEV Gen 2 columns.

When it comes to EV isolation for cancer diagnostics, picking the right methodology could be the difference between succeeding in diagnostics versus failing to achieve sufficient specificity and sensitivity. With qEV columns excelling in purity, your biomarker has a stronger chance at standing out amongst the background noise.

Regulations in nanomedicine are lacking, with no global consensus on definitions and a lack of clarity around which attributes are critical to safety. However, some initiatives and guidelines are in place which may provide indications of what to expect in the future.

Using qEV columns to determine cargo truly associated with extracellular vesicles and evaluate its biomarker potential in breast cancer: a summary of work by Tkach et al 2022.

The Exoid is yet to reach its second birthday, yet it has already appeared in a number of impressive research articles. Here are our top 3 extracellular vesicle studies featuring the Exoid to date.

Has changing your isolation method changed your EV isolate bioactivity? Or perhaps even their cargo or markers? Here’s why.

The Exoid is a highly accurate, highly tunable device which measures single particles in real time for size, concentration and zeta potential. But don’t just take our word for it. We have the data to back it up.

The qEV2 Gen 2 column is the sixth column to join the Gen 2 range; launched on 17th Jan 2023.

When is an extracellular vesicle an exosome? Turns out, probably less often than you think. Here we delve into EV subtypes and the (lack of) markers to tell them apart.

Urine is a rich source of EV biomarkers, yet methodology lags behind modern, standardised technology. New studies show size exclusion chromatography as the way forward.

A summary of work by Chiang et al. 2022, feat. qEV and TRPS for studying OMVs from a nosocomial bacterial pathogen.

In conversation with Michiel Pegtel, Principal Investigator at Amsterdam UMC and co-founder of Exbiome, about extracellular vesicle isolation, diagnostics, and EV-miRNA biomarker development.

World Prematurity Day is recognised on November 17 to raise awareness of the challenges of preterm birth. What role might extracellular vesicles play in this space?

Preeclampsia is a major contributor to premature birth. How might extracellular vesicles play a role in pathogenesis, prediction, and treatment?

Breaking it down: why choose qEV columns for extracellular vesicle isolation?

Synovial fluid is a highly viscous biofluid containing immune cell-derived extracellular vesicles which could prove key to arthritides, but how should you isolate them? And what is already known about them?

Publications featuring Tunable Resistive Pulse Sensing (TRPS) from Q3, 2022.

The qEV isolation platform continues to contribute to high quality research, as seen in publications from Q3 2022.

Cerebrospinal Fluid presents unique challenges for EV isolation, which has been reflected in a lack of reproducibility in research.

The methods you use for blood collection and processing will impact on the EVs that end up in your isolated sample. Here we discuss the evidence to help you make the right decisions for your research.

Interested in using the qEV10 in your research? Here we highlight some of the best examples of research using qEV10 columns published to date.

Isolation, function, and potential future uses of extracellular vesicles derived from milk – a complex and commonly overlooked biofluid.

The qEV Gen 2 range just got bigger: qEV100 joins the Gen 2 range.

A selection of publications feat. TRPS from Q2, 2022.